Clinical Trials · NCT05320406
RElugolix VErsus LeUprolide Cardiac Trial
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Emory University
- Enrollment
- 94
- Start date
- Jun 2022
- Locations
- 4 sites, United States
- Primary endpoint
- Total Coronary Plaque Volume in Major Coronary Arteries (i.e. Left Anterior Descending, Left Circumflex, Right Major Coronary Arteries)